港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

宜明昂科-B

4.160

-0.280-6.31%

成交量：232.80萬

成交額：980.43萬

市值：17.97億

市盈率：-5.27

高：4.440

開：4.440

低：4.130

收：4.440

52周最高：16.800

52周最低：4.130

股本：4.32億

香港流通股本：4.20億

量比：2.12

換手率：0.55%

股息：- -

股息率：- -

每股收益(LYR):-0.790

淨資產收益率：-53.53%

總資產收益率：-25.66%

市淨率：2.99

市盈率(LYR):-5.27

市銷率: 13.00

資料載入中...

總覽公司新聞資訊公告

每日沽空追蹤 | 宜明昂科-B 01月15日沽空量成交1.16萬股，沽空比例為1.19%

宜明昂科-B01月15日遭主力拋售7.7萬元

艾伯維再砸下56億美元！為什麼MNC熱衷雙抗？

动脉新医药

宜明昂科-B01月14日主力淨流出169.3萬元散户資金買入

張江藥谷企業加速從實驗室到全球市場

港股生物醫藥股集體走高！百奧賽圖-B升逾11%，來凱醫藥-B升逾5%

老虎资讯综合

每日沽空追蹤 | 宜明昂科-B 01月13日沽空量成交6萬股，沽空比例為2.47%

宜明昂科-B01月13日主力淨流入36.9萬元散户資金拋售

A股、港股醫藥股今日大漲，這些利好因素在刺激

宜明昂科-B(01541.HK)早盤升逾10%

每日经济新闻

港股異動 | 宜明昂科-B(01541)早盤升逾10% IMM01獲批進行動脈粥樣硬化治療的臨牀試驗

宜明昂科-B：國家藥監局批准Imm01（Timdarpacept）用於動脈粥樣硬化的臨牀試驗

宜明昂科-B(01541)：MM01(替達派西普)獲國家藥監局批准進行動脈粥樣硬化治療的臨牀試驗

中國創新藥，大爆發

艾美达医药咨询

宜明昂科-B盤中異動急速拉升5.38%

每日沽空追蹤 | 宜明昂科-B 01月08日沽空量成交4.88萬股，沽空比例為2.23%

國元國際：宜明昂科-B(01541)重獲IMM2510全球權利海外研發有望加速推進

智通财经网

宜明昂科－Ｂ(01541)股價下跌5.045%，現價港幣$6.4

阿斯达克财经

3500萬美元到賬後，宜明昂科超20億美元BD合作終止，創始人田文志：美國臨牀推進緩慢

收回海外權益宜明昂科(01541)戰略糾偏打開新空間

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/01541/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01541","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01541\",,,,,undefined,":{"symbol":"01541","market":"HK","secType":"STK","nameCN":"宜明昂科-B","latestPrice":4.16,"timestamp":1770192505002,"preClose":4.44,"halted":0,"volume":2328000,"delay":0,"changeRate":-0.06306306306306311,"floatShares":420477305,"shares":432000000,"eps":-0.79,"marketStatus":"未開盤","change":-0.28,"latestTime":"02-04 16:08:25","open":4.44,"high":4.44,"low":4.13,"amount":9804310,"amplitude":0.06982,"askPrice":4.21,"askSize":64000,"bidPrice":4.16,"bidSize":22000,"shortable":3,"etf":0,"ttmEps":-0.769,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1770255000000},"marketStatusCode":0,"adr":0,"listingDate":1693843200000,"exchange":"SEHK","adjPreClose":4.44,"openAndCloseTimeList":[[1770168600000,1770177600000],[1770181200000,1770192000000]],"volumeRatio":2.1242426454291894,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01541\",,,,,undefined,":{"symbol":"01541","floatShares":420477305,"roa":"-25.66%","roe":"-53.53%","lyrEps":-0.79,"volumeRatio":2.1242426454291894,"shares":432000000,"dividePrice":0,"high":4.44,"amplitude":0.06982,"preClose":4.44,"low":4.13,"week52Low":4.13,"pbRate":"2.99","psRate":"13.00","week52High":16.8,"institutionHeld":0,"latestPrice":4.16,"committee":-0.488372,"eps":-0.79,"divideRate":0,"volume":2328000,"delay":0,"ttmEps":-0.769,"open":4.44,"prevYearClose":5.83,"prevWeekClose":4.53,"prevMonthClose":4.53,"prevQuarterClose":5.83,"fiveDayClose":4.82,"twentyDayClose":6.74,"sixtyDayClose":7.9},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01541\",params:#limit:5,,,undefined,":[{"date":"2025-08-26","symbol":"01541","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null},{"date":"2025-03-25","symbol":"01541","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742866200000,"name":null,"time":"盤後","dateTimestamp":1742832000000,"actualEps":null},{"market":"HK","date":"2024-08-26","symbol":"01541","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1724601600000,"reportTimeType":"post","actualEps":null},{"date":"2024-03-25","symbol":"01541","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01541\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01541\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1697558400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01541\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01541","date":"2026-02-03","current":-5.409623,"percent":0.876047,"low":-30.003263,"twenty":-18.505272,"median":-12.701975,"eighty":-6.356675,"high":-2.993766,"avg":-13.140778,"sd":7.167869,"marketCap":1915894165},"quantilePoints":[{"date":"2023-08-31","current":-17.746094,"twenty":-17.746094,"median":-17.746094,"eighty":-17.746094,"marketCap":6942262047},{"date":"2023-09-08","current":-19.116691,"twenty":-19.083294,"median":-18.655615,"eighty":-17.801139,"marketCap":7390149921},{"date":"2023-09-15","current":-24.765877,"twenty":-24.765877,"median":-19.116691,"eighty":-18.557812,"marketCap":9648251285},{"date":"2023-09-22","current":-25.548224,"twenty":-25.200205,"median":-24.360534,"eighty":-18.753419,"marketCap":9909519212},{"date":"2023-09-29","current":-29.804324,"twenty":-26.447668,"median":-24.870232,"eighty":-19.083294,"marketCap":11580180660},{"date":"2023-10-06","current":-24.76052,"twenty":-26.458287,"median":-24.870232,"eighty":-19.110012,"marketCap":9615852761},{"date":"2023-10-13","current":-27.113287,"twenty":-26.458287,"median":-25.206314,"eighty":-22.322253,"marketCap":10513831229},{"date":"2023-10-20","current":-26.768577,"twenty":-26.795293,"median":-25.37532,"eighty":-23.788881,"marketCap":10364168151},{"date":"2023-10-27","current":-28.665306,"twenty":-27.124745,"median":-25.753577,"eighty":-24.00727,"marketCap":11093775656},{"date":"2023-11-03","current":-26.275244,"twenty":-27.500238,"median":-26.158488,"eighty":-24.473108,"marketCap":10195797188},{"date":"2023-11-10","current":-26.039628,"twenty":-27.37617,"median":-26.041732,"eighty":-24.763734,"marketCap":10102257765},{"date":"2023-11-17","current":-26.714897,"twenty":-27.225983,"median":-26.171076,"eighty":-24.792429,"marketCap":10457707575},{"date":"2023-11-24","current":-27.539565,"twenty":-27.37617,"median":-26.271304,"eighty":-24.846191,"marketCap":10869281039},{"date":"2023-12-01","current":-28.464343,"twenty":-27.564693,"median":-26.306056,"eighty":-24.874164,"marketCap":11280854504},{"date":"2023-12-08","current":-27.67933,"twenty":-27.70336,"median":-26.447668,"eighty":-25.070837,"marketCap":10925404694},{"date":"2023-12-15","current":-27.708906,"twenty":-27.817253,"median":-26.526325,"eighty":-25.207536,"marketCap":11000236233},{"date":"2023-12-22","current":-27.916049,"twenty":-27.937914,"median":-26.714897,"eighty":-25.244891,"marketCap":11075067772},{"date":"2023-12-29","current":-28.049426,"twenty":-27.986303,"median":-26.835368,"eighty":-25.288293,"marketCap":11187315080},{"date":"2024-01-05","current":-23.146888,"twenty":-27.970711,"median":-26.68937,"eighty":-25.200205,"marketCap":9166863527},{"date":"2024-01-12","current":-26.439512,"twenty":-27.935571,"median":-26.500765,"eighty":-25.200205,"marketCap":10476415460},{"date":"2024-01-19","current":-25.435754,"twenty":-27.916049,"median":-26.490281,"eighty":-25.212424,"marketCap":10064841995},{"date":"2024-01-26","current":-23.636611,"twenty":-27.83997,"median":-26.442842,"eighty":-24.972615,"marketCap":9316526605},{"date":"2024-02-02","current":-21.195554,"twenty":-27.817533,"median":-26.372788,"eighty":-24.783518,"marketCap":8343716598},{"date":"2024-02-09","current":-18.727145,"twenty":-27.802108,"median":-26.275244,"eighty":-24.041989,"marketCap":7408322361},{"date":"2024-02-16","current":-17.739662,"twenty":-27.801452,"median":-26.252628,"eighty":-23.794995,"marketCap":7019198358},{"date":"2024-02-23","current":-22.387155,"twenty":-27.764049,"median":-26.165159,"eighty":-23.13759,"marketCap":8811413717},{"date":"2024-03-01","current":-17.708555,"twenty":-27.735275,"median":-26.04068,"eighty":-22.460898,"marketCap":6974299434},{"date":"2024-03-08","current":-19.229551,"twenty":-27.718352,"median":-26.025076,"eighty":-21.141323,"marketCap":7576693323},{"date":"2024-03-15","current":-16.157629,"twenty":-27.69116,"median":-25.695795,"eighty":-19.998834,"marketCap":6360680815},{"date":"2024-03-22","current":-15.411367,"twenty":-27.66021,"median":-25.548224,"eighty":-19.057216,"marketCap":6061354659},{"date":"2024-03-28","current":-14.696214,"twenty":-27.629432,"median":-25.408294,"eighty":-18.737655,"marketCap":6038905197},{"date":"2024-04-05","current":-13.011166,"twenty":-27.602384,"median":-25.364375,"eighty":-18.557812,"marketCap":5342971884},{"date":"2024-04-12","current":-13.094845,"twenty":-27.539565,"median":-25.225009,"eighty":-18.239836,"marketCap":5380387654},{"date":"2024-04-19","current":-13.014894,"twenty":-27.51439,"median":-25.154554,"eighty":-17.708555,"marketCap":5342971884},{"date":"2024-04-26","current":-13.779237,"twenty":-27.443648,"median":-24.972615,"eighty":-16.602696,"marketCap":5649781194},{"date":"2024-05-03","current":-12.839078,"twenty":-27.434442,"median":-24.870232,"eighty":-16.184677,"marketCap":5260657191},{"date":"2024-05-10","current":-13.282389,"twenty":-27.357513,"median":-24.774698,"eighty":-14.702373,"marketCap":5455219193},{"date":"2024-05-17","current":-13.228926,"twenty":-27.225983,"median":-24.581805,"eighty":-14.243189,"marketCap":5425286577},{"date":"2024-05-24","current":-13.350651,"twenty":-27.145452,"median":-23.955191,"eighty":-13.966896,"marketCap":5462702347},{"date":"2024-05-31","current":-13.410156,"twenty":-27.124745,"median":-23.750163,"eighty":-13.747349,"marketCap":5492634962},{"date":"2024-06-07","current":-14.158514,"twenty":-27.039336,"median":-23.288627,"eighty":-13.645876,"marketCap":5791961118},{"date":"2024-06-14","current":-13.347574,"twenty":-26.971042,"median":-23.123643,"eighty":-13.527845,"marketCap":5455219193},{"date":"2024-06-21","current":-13.283836,"twenty":-26.926395,"median":-22.448608,"eighty":-13.452996,"marketCap":5417803423},{"date":"2024-06-28","current":-12.683619,"twenty":-26.848726,"median":-21.974147,"eighty":-13.40419,"marketCap":5170859344},{"date":"2024-07-05","current":-11.291057,"twenty":-26.759122,"median":-21.059976,"eighty":-13.359292,"marketCap":4602139648},{"date":"2024-07-12","current":-12.246119,"twenty":-26.720023,"median":-20.206581,"eighty":-13.323498,"marketCap":4998746805},{"date":"2024-07-19","current":-11.915911,"twenty":-26.704686,"median":-19.229551,"eighty":-13.282563,"marketCap":4864050035},{"date":"2024-07-26","current":-11.780484,"twenty":-26.652155,"median":-19.050696,"eighty":-13.224977,"marketCap":4826634265},{"date":"2024-08-02","current":-13.633124,"twenty":-26.594701,"median":-18.753419,"eighty":-13.20236,"marketCap":5582432809},{"date":"2024-08-09","current":-9.567144,"twenty":-26.54166,"median":-18.630761,"eighty":-13.102374,"marketCap":3943622105},{"date":"2024-08-16","current":-8.483685,"twenty":-26.496571,"median":-18.451463,"eighty":-13.086665,"marketCap":3498374448},{"date":"2024-08-23","current":-8.095604,"twenty":-26.47337,"median":-18.020488,"eighty":-13.035717,"marketCap":3352452947},{"date":"2024-08-30","current":-7.377309,"twenty":-26.446703,"median":-17.739662,"eighty":-12.990136,"marketCap":3034418906},{"date":"2024-09-06","current":-4.227864,"twenty":-26.442176,"median":-17.681919,"eighty":-12.840212,"marketCap":1739833281},{"date":"2024-09-13","current":-4.503325,"twenty":-26.43833,"median":-16.602696,"eighty":-12.741292,"marketCap":1848339013},{"date":"2024-09-20","current":-4.539912,"twenty":-26.433601,"median":-16.202037,"eighty":-12.246119,"marketCap":1874530051},{"date":"2024-09-27","current":-5.476578,"twenty":-26.311976,"median":-15.844451,"eighty":-11.915911,"marketCap":2274878785},{"date":"2024-10-04","current":-6.596451,"twenty":-26.302504,"median":-15.05764,"eighty":-11.832338,"marketCap":2727609596},{"date":"2024-10-10","current":-5.983695,"twenty":-26.285201,"median":-14.496802,"eighty":-11.807116,"marketCap":2458216056},{"date":"2024-10-18","current":-5.191078,"twenty":-26.27288,"median":-14.209972,"eighty":-11.719903,"marketCap":2121474130},{"date":"2024-10-25","current":-7.104995,"twenty":-26.248892,"median":-14.119017,"eighty":-11.287262,"marketCap":2903463713},{"date":"2024-11-01","current":-6.615271,"twenty":-26.199776,"median":-13.881638,"eighty":-9.764235,"marketCap":2705160134},{"date":"2024-11-08","current":-6.847628,"twenty":-26.169892,"median":-13.803075,"eighty":-8.441853,"marketCap":2787474827},{"date":"2024-11-15","current":-7.078843,"twenty":-26.118271,"median":-13.690467,"eighty":-8.248986,"marketCap":2851081635},{"date":"2024-11-22","current":-6.784782,"twenty":-26.059844,"median":-13.633178,"eighty":-7.853303,"marketCap":2731351173},{"date":"2024-11-29","current":-5.682581,"twenty":-26.04047,"median":-13.539989,"eighty":-7.45767,"marketCap":2286103516},{"date":"2024-12-06","current":-5.602773,"twenty":-26.037499,"median":-13.514674,"eighty":-7.358253,"marketCap":2248687746},{"date":"2024-12-13","current":-6.121403,"twenty":-26.029477,"median":-13.45004,"eighty":-7.218028,"marketCap":2451992323},{"date":"2024-12-20","current":-5.137492,"twenty":-25.962318,"median":-13.411134,"eighty":-7.087735,"marketCap":2048757705},{"date":"2024-12-27","current":-4.957491,"twenty":-25.887099,"median":-13.400213,"eighty":-7.078006,"marketCap":1975442320},{"date":"2025-01-03","current":-5.238569,"twenty":-25.753577,"median":-13.368079,"eighty":-6.925822,"marketCap":2089488475},{"date":"2025-01-10","current":-5.002231,"twenty":-25.638014,"median":-13.3526,"eighty":-6.765934,"marketCap":1987661551},{"date":"2025-01-17","current":-5.018682,"twenty":-25.5579,"median":-13.317479,"eighty":-6.665777,"marketCap":1995807705},{"date":"2025-01-24","current":-5.323319,"twenty":-25.548224,"median":-13.283546,"eighty":-6.596451,"marketCap":2130219244},{"date":"2025-01-28","current":-5.224689,"twenty":-25.503236,"median":-13.282823,"eighty":-6.532117,"marketCap":2101707706},{"date":"2025-02-07","current":-5.549725,"twenty":-25.42477,"median":-13.246663,"eighty":-6.254752,"marketCap":2219826937},{"date":"2025-02-14","current":-5.930475,"twenty":-25.395104,"median":-13.220128,"eighty":-6.076947,"marketCap":2366457707},{"date":"2025-02-21","current":-6.375256,"twenty":-25.366564,"median":-13.201126,"eighty":-6.054191,"marketCap":2557892324},{"date":"2025-02-28","current":-5.632443,"twenty":-25.318672,"median":-13.116805,"eighty":-5.974648,"marketCap":2252411553},{"date":"2025-03-07","current":-5.782376,"twenty":-25.249925,"median":-13.099044,"eighty":-5.827424,"marketCap":2321653861},{"date":"2025-03-14","current":-4.421401,"twenty":-25.219975,"median":-13.087912,"eighty":-5.725677,"marketCap":1775861550},{"date":"2025-03-21","current":-4.778207,"twenty":-25.207536,"median":-13.071662,"eighty":-5.66584,"marketCap":1918419243},{"date":"2025-03-28","current":-6.735516,"twenty":-25.163684,"median":-13.026305,"eighty":-5.651503,"marketCap":2276850015},{"date":"2025-04-03","current":-7.956153,"twenty":-25.0977,"median":-13.01303,"eighty":-5.66026,"marketCap":2684157710},{"date":"2025-04-11","current":-6.344288,"twenty":-25.036833,"median":-12.972072,"eighty":-5.68428,"marketCap":2126146167},{"date":"2025-04-17","current":-6.122985,"twenty":-24.972615,"median":-12.844749,"eighty":-5.691075,"marketCap":2056903859},{"date":"2025-04-25","current":-8.576896,"twenty":-24.895951,"median":-12.836736,"eighty":-5.703559,"marketCap":2883738480},{"date":"2025-05-02","current":-7.700417,"twenty":-24.872853,"median":-12.82514,"eighty":-5.710649,"marketCap":2594550017},{"date":"2025-05-09","current":-7.730765,"twenty":-24.846191,"median":-12.683619,"eighty":-5.725677,"marketCap":2623061555},{"date":"2025-05-16","current":-8.311097,"twenty":-24.799485,"median":-12.12195,"eighty":-5.751942,"marketCap":2843007711},{"date":"2025-05-23","current":-11.289802,"twenty":-24.776462,"median":-11.940532,"eighty":-5.771038,"marketCap":3873496179},{"date":"2025-05-30","current":-15.223569,"twenty":-24.763734,"median":-11.970101,"eighty":-5.797425,"marketCap":5246123111},{"date":"2025-06-06","current":-16.623143,"twenty":-24.617548,"median":-12.331836,"eighty":-5.827424,"marketCap":5743038499},{"date":"2025-06-13","current":-15.603079,"twenty":-24.258649,"median":-12.701975,"eighty":-5.862056,"marketCap":5392753881},{"date":"2025-06-20","current":-14.878015,"twenty":-24.00727,"median":-12.82804,"eighty":-5.90109,"marketCap":5132076957},{"date":"2025-06-27","current":-13.023121,"twenty":-23.933348,"median":-12.837907,"eighty":-5.91626,"marketCap":4504823106},{"date":"2025-07-04","current":-14.906416,"twenty":-23.89321,"median":-12.895238,"eighty":-5.935244,"marketCap":5156515418},{"date":"2025-07-11","current":-12.022018,"twenty":-23.818294,"median":-12.972072,"eighty":-5.957179,"marketCap":4154538489},{"date":"2025-07-18","current":-12.975089,"twenty":-23.597552,"median":-12.895238,"eighty":-5.971632,"marketCap":4480384645},{"date":"2025-07-25","current":-12.316929,"twenty":-23.410778,"median":-12.839078,"eighty":-5.984465,"marketCap":4268584643},{"date":"2025-08-01","current":-12.109688,"twenty":-23.260279,"median":-12.895238,"eighty":-5.992729,"marketCap":4170830796},{"date":"2025-08-08","current":-13.046774,"twenty":-23.142239,"median":-12.972072,"eighty":-6.013995,"marketCap":4504823106},{"date":"2025-08-15","current":-15.594562,"twenty":-23.052783,"median":-12.982136,"eighty":-6.023266,"marketCap":5376461574},{"date":"2025-08-22","current":-14.245172,"twenty":-22.717488,"median":-13.011166,"eighty":-6.052989,"marketCap":4895838493},{"date":"2025-08-29","current":-13.416028,"twenty":-22.485479,"median":-13.022379,"eighty":-6.061027,"marketCap":4439653875},{"date":"2025-09-05","current":-17.224047,"twenty":-22.314693,"median":-13.032106,"eighty":-6.075447,"marketCap":5694161576},{"date":"2025-09-12","current":-15.065483,"twenty":-22.014704,"median":-13.063177,"eighty":-6.087386,"marketCap":4989519263},{"date":"2025-09-19","current":-14.903882,"twenty":-21.818428,"median":-13.085834,"eighty":-6.113201,"marketCap":4932496186},{"date":"2025-09-26","current":-13.980202,"twenty":-21.168438,"median":-13.096763,"eighty":-6.121719,"marketCap":4614796184},{"date":"2025-10-03","current":-19.067762,"twenty":-21.059976,"median":-13.099741,"eighty":-6.122985,"marketCap":6309196195},{"date":"2025-10-10","current":-15.483575,"twenty":-20.658991,"median":-13.109708,"eighty":-6.128239,"marketCap":5115784649},{"date":"2025-10-17","current":-12.892469,"twenty":-20.520951,"median":-13.123492,"eighty":-6.17051,"marketCap":4256365412},{"date":"2025-10-24","current":-11.824326,"twenty":-20.411262,"median":-13.104868,"eighty":-6.183537,"marketCap":3905144639},{"date":"2025-10-31","current":-11.96327,"twenty":-20.170656,"median":-13.098863,"eighty":-6.223751,"marketCap":3956925563},{"date":"2025-11-07","current":-10.312858,"twenty":-19.984772,"median":-13.08999,"eighty":-6.257081,"marketCap":3408910790},{"date":"2025-11-14","current":-10.296734,"twenty":-19.520389,"median":-13.071805,"eighty":-6.311268,"marketCap":3413225867},{"date":"2025-11-21","current":-8.92105,"twenty":-19.161835,"median":-13.046774,"eighty":-6.362869,"marketCap":2955827710},{"date":"2025-11-28","current":-9.407815,"twenty":-19.096653,"median":-13.027047,"eighty":-6.414675,"marketCap":3128430788},{"date":"2025-12-05","current":-8.666243,"twenty":-19.073975,"median":-13.014894,"eighty":-6.44644,"marketCap":2886786479},{"date":"2025-12-12","current":-8.404571,"twenty":-19.037964,"median":-12.986335,"eighty":-6.450097,"marketCap":2804800017},{"date":"2025-12-19","current":-8.049417,"twenty":-18.988805,"median":-12.975089,"eighty":-6.476679,"marketCap":2692608016},{"date":"2025-12-24","current":-7.972984,"twenty":-18.926105,"median":-12.9589,"eighty":-6.505915,"marketCap":2675347709},{"date":"2026-01-02","current":-7.788017,"twenty":-18.753419,"median":-12.908879,"eighty":-6.55197,"marketCap":2623566785},{"date":"2026-01-09","current":-8.075331,"twenty":-18.727145,"median":-12.839078,"eighty":-6.58869,"marketCap":2727128632},{"date":"2026-01-16","current":-7.93455,"twenty":-18.70371,"median":-12.833897,"eighty":-6.596451,"marketCap":2688292939},{"date":"2026-01-23","current":-6.093671,"twenty":-18.557812,"median":-12.82514,"eighty":-6.55197,"marketCap":2062606782},{"date":"2026-01-30","current":-5.748685,"twenty":-18.530718,"median":-12.736832,"eighty":-6.440954,"marketCap":1954729858},{"date":"2026-02-03","current":-5.621359,"twenty":-18.505272,"median":-12.701975,"eighty":-6.356675,"marketCap":1915894165}],"updateTime":1770204198477},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01541\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2603931502","title":"每日沽空追蹤 | 宜明昂科-B 01月15日沽空量成交1.16萬股，沽空比例為1.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603931502","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603931502?lang=zh_tw&edition=fundamental","pubTime":"2026-01-15 16:30","pubTimestamp":1768465822,"startTime":"0","endTime":"0","summary":"宜明昂科-B北京时间01月15日，跌2.4%，卖空量成交1.16万股，较上一交易日减少83.75%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115164018a71dc735&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115164018a71dc735&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2603528931","title":"宜明昂科-B01月15日遭主力拋售7.7萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603528931","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603528931?lang=zh_tw&edition=fundamental","pubTime":"2026-01-15 16:16","pubTimestamp":1768464969,"startTime":"0","endTime":"0","summary":"01月15日, 宜明昂科-B股价跌2.40%，报收6.51元，成交金额634.0万元，换手率0.23%，振幅6.60%，量比0.51。宜明昂科-B今日主力资金净流出7.7万元，上一交易日主力净流出169.3万元。该股近5个交易日上涨1.72%，主力资金累计净流出55.6万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出4.9万元，其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115162617a4c6c34a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115162617a4c6c34a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2603628329","title":"艾伯維再砸下56億美元！為什麼MNC熱衷雙抗？","url":"https://stock-news.laohu8.com/highlight/detail?id=2603628329","media":"动脉新医药","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603628329?lang=zh_tw&edition=fundamental","pubTime":"2026-01-14 18:58","pubTimestamp":1768388288,"startTime":"0","endTime":"0","summary":"1月12日晚，荣昌生物宣布与艾伯维签署独家授权协议，将自主研发的PD-1/VEGF双特异性抗体药物RC148的大中华区以外全球权益授权给后者。毋庸置疑，双抗赛道诞生重磅交易已不是一件新鲜事，辉瑞、BMS和艾伯维等MNC也被卷入。正是看到这一价值，艾伯维、辉瑞等MNC纷纷重金布局，以期争夺下一代基石药物的主导权。针对荣昌生物与艾伯维达成的重磅BD，前述医药行业分析师告诉动脉网，早期交易多以new-co形式进行，而本次是直接的BD授权，且交易对手是MNC。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114190019a4c2fb59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114190019a4c2fb59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01541","LU0417516902.SGD","LU2399975544.HKD","09995","BK1574","IE00BPRC5H50.USD","LU2778985437.USD","IE00B5MMRT66.SGD","BK1583","LU1961090484.USD","LU2476274308.USD","LU1794554557.SGD","LU1720050803.USD","LU2328871848.SGD","LU0348767384.USD","LU0348827113.USD","LU0348825331.USD","LU0561508036.HKD","LU0634319403.HKD","LU0417516738.SGD","09926","LU2476274720.SGD","LU0348766576.USD","LU0348784397.USD","LU0348735423.USD","LU1969619763.USD","LU0348783233.USD","LU0540923850.HKD","BK1161","LU2488822045.USD","LU0417516571.SGD","IE00B543WZ88.USD"],"gpt_icon":0},{"id":"2603285936","title":"宜明昂科-B01月14日主力淨流出169.3萬元 散户資金買入","url":"https://stock-news.laohu8.com/highlight/detail?id=2603285936","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603285936?lang=zh_tw&edition=fundamental","pubTime":"2026-01-14 16:15","pubTimestamp":1768378545,"startTime":"0","endTime":"0","summary":"01月14日, 宜明昂科-B股价跌0.89%，报收6.67元，成交金额1305.7万元，换手率0.45%，振幅7.43%，量比0.85。宜明昂科-B今日主力资金净流出169.3万元，上一交易日主力净流入36.9万元。该股近5个交易日下跌0.89%，主力资金累计净流出8.9万元；近20日主力资金累计净流出3.5万元，其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114162112a4c258cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114162112a4c258cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2603646356","title":"張江藥谷企業加速從實驗室到全球市場","url":"https://stock-news.laohu8.com/highlight/detail?id=2603646356","media":"张江发布","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603646356?lang=zh_tw&edition=fundamental","pubTime":"2026-01-14 13:05","pubTimestamp":1768367141,"startTime":"0","endTime":"0","summary":"近期，多家张江药谷企业在新药申报、适应症拓展及技术平台突破等方面取得重要进展。张江药谷通过制度创新、服务创新、生态创新，持续推动创新成果高效转化，加速产品上市与迭代。此次获批标志着阿美乐实现了从早期到晚期EGFR突变NSCLC患者全病程的治疗覆盖。宜明昂科阿沐瑞芙普α单药治疗原发性膜性肾炎的IND获受理1月7日，张江药谷企业宜明昂科宣布，公司自主研发的阿沐瑞芙普α单药治疗原发性膜性肾炎的临床试验申请正式获得NMPA受理。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114131239953cb11d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114131239953cb11d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03692","BK1587","BK1191","BK1589","BK1583","BK1588","01541","00013"],"gpt_icon":0},{"id":"1130056406","title":"港股生物醫藥股集體走高！百奧賽圖-B升逾11%，來凱醫藥-B升逾5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1130056406","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130056406?lang=zh_tw&edition=fundamental","pubTime":"2026-01-14 09:43","pubTimestamp":1768354999,"startTime":"0","endTime":"0","summary":"1月14日，港股生物医药股集体走高，$百奥赛图-B(02315)$涨超11%，$来凯医药-B(02105)$、$宜明$昂科(02216)$-B(01541)$涨超5%，$微创$机器人(300024)$-B(02252)$涨超4%，$启明医疗-B(02500)$、$华领医药-B(02552)$涨超3%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c007f4db8ce2cc0ef142359e6d915978","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541","BK1161","BK1191","02315","BK1574","02552","BK1100","BK1583","BK1617","02105","02500","02216","02252"],"gpt_icon":0},{"id":"2603689398","title":"每日沽空追蹤 | 宜明昂科-B 01月13日沽空量成交6萬股，沽空比例為2.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603689398","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603689398?lang=zh_tw&edition=fundamental","pubTime":"2026-01-13 16:30","pubTimestamp":1768293022,"startTime":"0","endTime":"0","summary":"宜明昂科-B北京时间01月13日，涨9.61%，卖空量成交6万股，较上一交易日增加9.49%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113164231a714fb36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113164231a714fb36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2603689316","title":"宜明昂科-B01月13日主力淨流入36.9萬元 散户資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2603689316","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603689316?lang=zh_tw&edition=fundamental","pubTime":"2026-01-13 16:15","pubTimestamp":1768292108,"startTime":"0","endTime":"0","summary":"01月13日, 宜明昂科-B股价涨9.61%，报收6.73元，成交金额1614.4万元，换手率0.58%，振幅9.45%，量比1.23。宜明昂科-B今日主力资金净流入36.9万元，上一交易日主力净流出15.5万元。该股近5个交易日上涨2.75%，主力资金累计净流入103.1万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入166.0万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113161540a714df7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113161540a714df7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2603950262","title":"A股、港股醫藥股今日大漲，這些利好因素在刺激","url":"https://stock-news.laohu8.com/highlight/detail?id=2603950262","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603950262?lang=zh_tw&edition=fundamental","pubTime":"2026-01-13 11:37","pubTimestamp":1768275475,"startTime":"0","endTime":"0","summary":"1月13日上午，A股以及港股的医药股集体出现走强趋势。当前，已有重磅对外授权交易揭晓。这笔交易刺激了A股、港股市场中的一些双抗概念股股价大涨，1月13日上午，宜明昂科港股股价盘中涨幅一度超过10.10%；三生国健A股股价涨幅也超过4%。同样，A股以及港股的医药外包股齐齐出现股价大涨局面，如药明康德A股跟港股上午盘中股价涨幅超过6%；药明生物股价涨幅也超过5%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113113932a4bcec89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113113932a4bcec89&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0823426480.USD","BK1161","LU0456827905.SGD","LU0320764599.SGD","LU0052750758.USD","LU0588546209.SGD","LU0327786744.USD","LU0819121731.USD","LU1720050803.USD","LU2328871848.SGD","LU1242518931.SGD","LU3063872942.SGD","02179","LU1880383366.USD","LU0181495838.USD","LU0417516738.SGD","BK1610","LU0359202008.SGD","LU2039709279.SGD","09995","LU0417516902.SGD","LU0039217434.USD","LU0043850808.USD","LU0348825331.USD","LU1242518857.USD","LU0516423174.USD","BK1574","02616","02126","BK1515","LU0856984785.SGD","LU0307460666.USD","LU0516422952.EUR","LU0516422440.USD","LU0516422366.SGD","LU0708995583.HKD","LU0979878070.USD","LU1969619763.USD","SG9999002562.SGD","LU0516423091.SGD","LU1688375341.USD","BK1576","IE00B0JY6N72.USD","01541","LU1794554557.SGD","02269","LU0051755006.USD","LU0823426308.USD","LU0359201612.USD","09939"],"gpt_icon":0},{"id":"2603571307","title":"宜明昂科-B(01541.HK)早盤升逾10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603571307","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603571307?lang=zh_tw&edition=fundamental","pubTime":"2026-01-13 11:22","pubTimestamp":1768274576,"startTime":"0","endTime":"0","summary":"每经AI快讯，宜明昂科-B(01541.HK)早盘涨超10%，截至发稿涨8.63%，报6.67港元，成交额1119.65万港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601133617117271.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601133617117271.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2603579817","title":"港股異動 | 宜明昂科-B(01541)早盤升逾10% IMM01獲批進行動脈粥樣硬化治療的臨牀試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2603579817","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603579817?lang=zh_tw&edition=fundamental","pubTime":"2026-01-13 11:09","pubTimestamp":1768273789,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，宜明昂科-B早盘涨超10%，截至发稿，涨8.63%，报6.67港元，成交额1119.65万港元。消息面上，宜明昂科发布公告，本集团已获中国国家药品监督管理局批准进行IMM01用于治疗动脉粥样硬化的临床试验。据悉，集团拥有IMM01的全球知识产权及商业化权利。国元国际发布研报称，此前公司重新获得IMM2510及IMM27M全球权利，重掌海外临床研发的主导权，将加速全球开发节奏。2510临床数据优秀，安全性良好，差异化优势明显。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1392062.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股异动 | 宜明昂科-B(01541)早盘涨超10% IMM01获批进行动脉粥样硬化治疗的临床试验","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"1141643309","title":"宜明昂科-B：國家藥監局批准Imm01（Timdarpacept）用於動脈粥樣硬化的臨牀試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=1141643309","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141643309?lang=zh_tw&edition=fundamental","pubTime":"2026-01-12 17:31","pubTimestamp":1768210314,"startTime":"0","endTime":"0","summary":"免疫肿瘤生物制药公司——宜明昂科宣布，其核心产品Imm01（研发代号：Timdarpacept）已获得中国国家药品监督管理局（NMPA）的临床试验批准，将针对动脉粥样硬化适应症展开临床研究。这一重要进展标志着该创新疗法在心血管疾病治疗领域的应用迈出了关键一步，有望为患者带来新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2602518816","title":"宜明昂科-B(01541)：MM01(替達派西普)獲國家藥監局批准進行動脈粥樣硬化治療的臨牀試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2602518816","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602518816?lang=zh_tw&edition=fundamental","pubTime":"2026-01-12 17:25","pubTimestamp":1768209924,"startTime":"0","endTime":"0","summary":"智通财经APP讯，宜明昂科-B 发布公告，本集团已获中国国家药品监督管理局批准进行IMM01用于治疗动脉粥样硬化的临床试验。凭藉差异化的分子设计，IMM01 表现出良好的安全性并证实其激活巨噬细胞的能力。IMM01联合阿扎胞苷进行CMML一线治疗于2023年11月获美国食品药品监督管理局授予的孤儿药资格认定。本集团拥有IMM01的全球知识产权及商业化权利。截至本公告日期，就IMM01而言，本集团拥有一个专利家族，其中包括在中国、美国、日本及欧盟的已授权专利。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391659.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"宜明昂科-B(01541)：MM01(替达派西普)获国家药监局批准进行动脉粥样硬化治疗的临床试验","news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2603250355","title":"中國創新藥，大爆發","url":"https://stock-news.laohu8.com/highlight/detail?id=2603250355","media":"艾美达医药咨询","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603250355?lang=zh_tw&edition=fundamental","pubTime":"2026-01-12 15:01","pubTimestamp":1768201310,"startTime":"0","endTime":"0","summary":"01规模、地位医药魔方数据库显示，截至2025年12月31日，中国创新药BD出海授权全年交易总额和交易事件数均创历史新高，交易总额1365.55亿美元，较上年增加840亿美元，增长了1.6倍；交易事件157起，较上年增加63起，增长67%。中国创新的国际认可度和全球影响力不断提高，中国创新药已成功跻身全球创新版图核心阵营。据信达生物方面介绍，该笔交易是中国创新药企当中唯一一家首付款超过10亿美金的共同开发、共同商业化BD战略合作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112154226a71089e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112154226a71089e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","06978","BK1161","01541","00013"],"gpt_icon":0},{"id":"2603250375","title":"宜明昂科-B盤中異動 急速拉升5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603250375","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603250375?lang=zh_tw&edition=fundamental","pubTime":"2026-01-12 09:30","pubTimestamp":1768181435,"startTime":"0","endTime":"0","summary":"2026年01月12日早盘09时30分，宜明昂科-B股票出现波动，股价急速上涨5.38%。宜明昂科-B股票所在的生物技术行业中，整体涨幅为2.04%。其相关个股中，瑞博生物-B、晶泰控股、宜明昂科-B涨幅较大，振幅较大的相关个股有瑞博生物-B、百奥赛图-B、北海康成-B，振幅分别为5.05%、4.90%、3.14%。宜明昂科-B公司简介：宜明昂科生物医药技术(上海)股份有限公司是一家主要从事测试生物技术研发的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112093035953c574d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112093035953c574d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2602348445","title":"每日沽空追蹤 | 宜明昂科-B 01月08日沽空量成交4.88萬股，沽空比例為2.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602348445","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602348445?lang=zh_tw&edition=fundamental","pubTime":"2026-01-08 16:30","pubTimestamp":1767861023,"startTime":"0","endTime":"0","summary":"宜明昂科-B北京时间01月08日，跌5.19%，卖空量成交4.88万股，较上一交易日减少43.52%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108164531a4ab4395&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108164531a4ab4395&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2601540653","title":"國元國際：宜明昂科-B(01541)重獲IMM2510全球權利 海外研發有望加速推進","url":"https://stock-news.laohu8.com/highlight/detail?id=2601540653","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601540653?lang=zh_tw&edition=fundamental","pubTime":"2026-01-08 15:09","pubTimestamp":1767856165,"startTime":"0","endTime":"0","summary":"公司与Axion订立终止协议，收回此前授予Axion的全球开发及商业化权利，仅保留Axion逐步结束临床开发活动的有限许可。","market":"us","thumbnail":"https://img.zhitongcaijing.com/image/20260108/20260108151004_11502.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260108/20260108151004_11502.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1390302.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2601346593","title":"宜明昂科－Ｂ(01541)股價下跌5.045%，現價港幣$6.4","url":"https://stock-news.laohu8.com/highlight/detail?id=2601346593","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601346593?lang=zh_tw&edition=fundamental","pubTime":"2026-01-08 11:45","pubTimestamp":1767843900,"startTime":"0","endTime":"0","summary":"[下跌股]宜明昂科－Ｂ(01541) 股价在上午11:45比前收市价下跌5.045%，现股价为港币$6.4。至目前为止，今日最高价为$6.81，而最低价为$6.4。总成交量为124.72万股，总成交金额为港币$814.677万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725131625844_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725131625844_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2601082579/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2601082579/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2601316386","title":"3500萬美元到賬後，宜明昂科超20億美元BD合作終止，創始人田文志：美國臨牀推進緩慢","url":"https://stock-news.laohu8.com/highlight/detail?id=2601316386","media":"时代财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601316386?lang=zh_tw&edition=fundamental","pubTime":"2026-01-07 19:19","pubTimestamp":1767784795,"startTime":"0","endTime":"0","summary":"宜明昂科为何与美国药企终止协议？此次终止不影响宜明昂科已从Axion收到的3500万美元首付款和里程碑付款。临床试验进展乏力成为此次合作终止的导火索。去年8月是宜明昂科最后一次收到BD交易款项，过往五次总计金额为3500万美元，这也是此次交易终止时不可退还的款项。随着BD款项陆续到账，双方的合作项目也在持续推进。但实际上，在2026年开年不到一周，宜明昂科与Instil Bio双方就终止了合作。据公开资料，其于2025年4月开始担任这一职位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107192006a6fe8396&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107192006a6fe8396&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0348827113.USD","LU2488822045.USD","LU0540923850.HKD","LU2778985437.USD","LU0634319403.HKD","LU0348767384.USD","LU2399975544.HKD","LU1794554557.SGD","LU0348766576.USD","LU2476274720.SGD","IE00B5MMRT66.SGD","BK1574","LU1961090484.USD","LU0348825331.USD","LU0561508036.HKD","LU0348783233.USD","01541","09926","IE00B543WZ88.USD","LU0417516902.SGD","LU2476274308.USD","LU1720050803.USD","LU0417516738.SGD","LU0348735423.USD","TIL","BK1161","LU0348784397.USD","IE00BPRC5H50.USD","LU0417516571.SGD"],"gpt_icon":0},{"id":"2601849078","title":"收回海外權益 宜明昂科(01541)戰略糾偏打開新空間","url":"https://stock-news.laohu8.com/highlight/detail?id=2601849078","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601849078?lang=zh_tw&edition=fundamental","pubTime":"2026-01-07 08:00","pubTimestamp":1767744020,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，宜明昂科昨天盘后宣布从Instil Bio收回IMM2510和IMM27M的全球权益，标志着公司主动修正了之前的授权策略。宜明昂科另一核心看点是CD47系列管线。随后该领域陆续落地了多项早期平台型合作，证明了MCE的战略价值。宜明昂科的IMM0306是进展最快的MCE分子之一。综合来看，此次权益回收让宜明昂科重新掌握重要资产主导权，叠加IMM01、IMM0306管线在肿瘤和自免领域的差异化布局，公司后续临床进展和BD合作值得期待。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1389584.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01541"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":182,"code":"91000000","status":"200"}]}}